Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 14.49
1.97 %
$ 918 M
Market Cap
-15.92
P/E
EOLS - COST OF REVENUE
Cost of Revenue EOLS - Evolus, Inc.
61.6 M
LAST VALUE
18.91%
2 YEAR CAGR
484.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR